Lycera Secures $4,000,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aff47ee7-21cb-4375-908e-0b81bc4160af - Date
4/7/2014 - Company Name
Lycera - Mailing Address
2800 Plymouth Rd. Ann Arbor, MI 48109 USA - Company Description
Lycera is an early-stage pharmaceutical company developing first-in-class drugs to treat immune disorders. Lycera’s technology platforms include proprietary small molecules that modulate a target, which is central to cellular bioenergetics along with molecules that target the Th17 pathway. - Website
http://www.lycera.com - Transaction Type
Debt - Transaction Amount
$4,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
